Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00962000 · ClinicalTrials.gov registry record · NA
Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate
A NA study, sponsored by Vantive Health.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT00962000 is a NA study that has completed, run by Vantive Health. The registered enrollment target is 42 participants.
The verdict
NCT00962000, a NA study, has completed, sponsored by Vantive Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The purpose of this study is to look at how the dose of dialysis is affected by the rate at which dialysate flows through the dialyzer. The dose of dialysis (Kt/V) will be determined by measuring blood levels of urea at the beginning and end of dialysis at two different dialysate flow rates.
Interventions
- OTHER Dialysis Flow Rate Start 600mL/min
- OTHER Dialysis Flow Rate Start 800mL/min
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00962000
The ClinicalTrials.gov registry entry for NCT00962000 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vantive Health, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dialysis Flow Rate Start 600mL/min is the first listed.
NCT00962000 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00962000 about?
NCT00962000 is a clinical study titled "Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate". The purpose of this study is to look at how the dose of dialysis is affected by the rate at which dialysate flows through the dialyzer. The dose of dialysis (Kt/V) will be determined by measuring blood levels of urea at the beginning and end of dialysis at two different dialysate flow rates.
What is the current status of trial NCT00962000?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2009-09. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00962000?
The interventions under investigation include: Dialysis Flow Rate Start 600mL/min (OTHER), Dialysis Flow Rate Start 800mL/min (OTHER).
Who is sponsoring clinical trial NCT00962000?
This trial is sponsored by Vantive Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.